16
Jun
2020
18:00
BST
Webinar
CCM® Around the World
-
Views:
2132
-
Likes:
2
Overview
This live online webinar is an educational program designed to share the latest updates on a breakthrough device-based therapy for the treatment of moderate to severe heart failure. While cardiac contractility modulation using the Optimizer® device has been well-studied, published and widely available in Europe for a number of years, it was only recently approved in the US. The use of CCM® therapy continues to expand rapidly – which makes now a perfect time to bring the world's most experienced investigators and providers with extensive clinical experience together to discuss the current and future place CCM® may take in the treatment of heart failure.
Faculty:
Thomas M Helms
Karl-Heinz Kuck
William T Abraham
Daniel Burkhoff
Frieder Braunschweig
Jürgen Kuschyk
This webinar is supported by
Agenda
Learning Objectives
- Become aware of the history of Impulse Dynamics and it's founding by a renowned scientist inventor.
- Appreciate the extensive scientific endeavours that resulted in the outcomes that have driven approval by the various regulatory authorities.
- Learn about the mode of action that underpins CCM® therapy.
- Understand the clinical path forward for CCM® therapy.
- Gain an understanding of appropriate patient identification and selection.
- Share patient experiences via case studies presented by the physician with the most extensive clinical experience in the world.
Faculty Biographies
Karl-Heinz Kuck
Prof Karl-Heinz Kuck is the Medical Director at LANS Cardio Hamburg. For many years, he was head of the Department of Cardiology at the Asklepios Klinik St. Georg in Hamburg. In addition, Prof Kuck was President of the European Heart Rhythm Association and President of the German Society for Cardiology.
He has earned several prizes for his work, including the Science Prize of the Gertrud Spitz Foundation and a silver badge of honor from the German Society for Cardiology – Heart and Circulatory Research. Prof Dr Kuck is also Section Editor – Clinical Electrophysiology and Ablation at Arrhythmia & Electrophysiology Review.
Prof Kuck is on the AER editorial board.
William T Abraham
Prof Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years.
His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve stimulation, cardiac contractility modulation, baroreflex activation therapy, and mitral valve repair.
Prof Abraham has authored more than 1,000 original works and has been named a Clarivate Analytics Highly Cited Researcher and one of The World’s Most Influential Scientific Minds.
He received the 2017 Distinguished Scientist Award from the American College of Cardiology.
With his permission, Prof Abraham is contactable here.
Frieder Braunschweig
Prof Frieder Braunschweig is the Director of Cardiology at Karolinska University Hospital, Stockholm, SE and a Professor at Karolinska Institutet in Stockholm, SE.
His clinical focus areas include invasive electrophysiology, cardiac pacing, heart failure and sports cardiology.